How to improve immunization in children and adolescents?

Professor Robert Jacobson shares his thoughts on how to improve immunization in children and adolescents.

New directions in Asthma and COPD

Monica Kraft, MD, FCCP shares her thoughts on the new directions in Asthma and COPD.

Comparison of GINA and EPR-4 Asthma Guidelines

Shahid Sheikh, MD, FCCP shares his thoughts on the GINA and EPR-4 Asthma Guidelines.

Importance of Vaccinations for Patients With Pulmonary Conditions

Shekhar Ghamande,  MBBS, MD, FCCP shares his thoughts on the importance of vaccinations for patients with pulmonary conditions. The important role of the RSV, meningococcal, influenza and COVID vaccines will also be explained.

Breathing Easier: The Evolution and Future of Asthma Care

Sandhya Khurana, MD, FCCP held the prestigious Mark J. Rosen, MD, Master FCCP Endowed Memorial Lecture at CHEST 2024. We asked her about the lecture and the future of asthma care.

How to manage acute PE? Follow the five D!

Bhavinkumar Dalal, FACP, MBBS, MD, FCCP chaired a very interesting presentation on controversies for the management of acute pulmonary embolism at CHEST 2024.

Update in Vaccines for RSV, COVID, Influenza

Aanchal Kapoor,  MD, FCCP shares her thoughts on updates in RSV, COVID and influenza vaccines.

Duchenne Muscular Dystrophy, Then and Now: Lessons from Respiratory Medicine

David J. Birnkrant, MD, FCCP held the prestigious Margaret Pfrommer Endowed Memorial Lecture In Home-Based Mechanical Ventilation at CHEST 2024. We asked him about the lecture and the Duchenne Muscular Dystrophy.

Advanced Management Strategies in Severe Asthma and COPD

Muhammad Adrish, MBA, MD, FCCP shares his thoughts on personalized treatment strategies for severe asthma and COPD.

CHEST Guidelines on Biologics for Severe Asthma: Evidence, Recommendations, and Clinical Implications

Megan Conroy, MD, MAEd, FCCP and Amber Oberle, MD  share their thoughts about CHEST guidelines on #biologics for severe asthma.

The role of LABA/LAMA and triple therapy for patients with COPD in GOLD Group E

Nicola Hanania, MS, MD, FCCP participated in a pro-con debate on the role of LABA/LAMA and triple therapy in patients with COPD. He shared his thoughts on the topic. 

Hemodynamic Assessment in Pulmonary Arterial Hypertension - Obtaining the Most Out of Right Heart Catheterization

Adriano Tonelli, MD shares his thoughts on hemodynamic assessment in pulmonary arterial hypertension.

Portopulmonary Hypertension: How Should We Think About it?

Hilary Dubrock, MD shares her thoughts on portopulmonary hypertension and explains how we should think about it.

Beyond Bronchodilators: Bronchoscopic Management of COPD

Jonathan Kurman,  MBA, MD, FCCP shares his thoughts on bronchoscopic management of COPD.

Evaluation and Management of VTE in Pregnancy

Lisa Moores, MD, FCCP shares her thoughts on evaluation and management of VTE in pregnancy.

Interplay of Pregnancy and Sleep

Ghada Bourjeily,  MD, FCCP participated in an interesting session about precision medicine for sleep disorders in women, and eplaneined her thoughts on the interplay of pregnancy and sleep.

Role of immunoncology in lung cancer treatment

Immunotherapy in lung cancer

Important recent developments in oncology

EGFR and ALK mutations in NSCLC

Sequencing the mesothelioma genom

The proper treatment algorithm for non-oncogene driven NSCLC

Phase 2 trial of nivolumab in NSCLC

Multidisciplinary approach in lung cancer treatment

Immunotherapy as first-line treatment for NSCLC

LBA2_PR - EGFR mutation testing and oncologist treatment choice in advanced NSCLC

Role of checkpoint inhibitors in lung cancer treatment

Targeted therapy in lung cancer

The Lung Cancer Master Protocol

Surgical perspective of lung cancer treatment

Fight on tuberculosis

Launch of one of the world's largest ever lung health campaigns